173 related articles for article (PubMed ID: 15212172)
1. Pharmacokinetic analysis of ramatroban using a recirculatory model with enterohepatic circulation by measuring portal and systemic blood concentration difference in Sprague-Dawley and Eisai hyperbilirubinemic rats.
Moriwaki T; Yasui H; Yamamoto A
Pharm Res; 2004 Jun; 21(6):1055-64. PubMed ID: 15212172
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics and metabolism of the new thromboxane A2 receptor antagonist ramatroban in animals. 1st communication: absorption, concentrations in plasma, metabolism, and excretion after single administration to rats and dogs.
Boberg M; Ahr HJ; Beckermann B; Bühner K; Siefert HM; Steinke W; Wünsche C; Hirayama M
Arzneimittelforschung; 1997 Aug; 47(8):928-38. PubMed ID: 9296279
[TBL] [Abstract][Full Text] [Related]
3. A recirculatory model with enterohepatic circulation by measuring portal and systemic blood concentration difference.
Moriwaki T; Yasui H; Yamamoto A
J Pharmacokinet Pharmacodyn; 2003 Apr; 30(2):119-44. PubMed ID: 12942684
[TBL] [Abstract][Full Text] [Related]
4. Impact of Mrp2 on the biliary excretion and intestinal absorption of furosemide, probenecid, and methotrexate using Eisai hyperbilirubinemic rats.
Chen C; Scott D; Hanson E; Franco J; Berryman E; Volberg M; Liu X
Pharm Res; 2003 Jan; 20(1):31-7. PubMed ID: 12608533
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics and metabolism of the new thromboxane A2 receptor antagonist ramatroban in animals. 2nd communication: distribution to organs and tissues in male, female and pregnant rats, and characteristics of protein binding in plasma.
Steinke W; Ahr HJ; Hirayama M
Arzneimittelforschung; 1997 Aug; 47(8):939-48. PubMed ID: 9296280
[TBL] [Abstract][Full Text] [Related]
6. Both cMOAT/MRP2 and another unknown transporter(s) are responsible for the biliary excretion of glucuronide conjugate of the nonpeptide angiotensin II antagonist, telmisaltan.
Nishino A; Kato Y; Igarashi T; Sugiyama Y
Drug Metab Dispos; 2000 Oct; 28(10):1146-8. PubMed ID: 10997931
[TBL] [Abstract][Full Text] [Related]
7. Increase in bile flow and biliary excretion of glutathione-derived sulfhydryls in rats by drug-metabolizing enzyme inducers is mediated by multidrug resistance protein 2.
Johnson DR; Habeebu SS; Klaassen CD
Toxicol Sci; 2002 Mar; 66(1):16-26. PubMed ID: 11861969
[TBL] [Abstract][Full Text] [Related]
8. Involvement of transporters in the hepatic uptake and biliary excretion of valsartan, a selective antagonist of the angiotensin II AT1-receptor, in humans.
Yamashiro W; Maeda K; Hirouchi M; Adachi Y; Hu Z; Sugiyama Y
Drug Metab Dispos; 2006 Jul; 34(7):1247-54. PubMed ID: 16624871
[TBL] [Abstract][Full Text] [Related]
9. Mrp2 is involved in benzylpenicillin-induced choleresis.
Ito K; Koresawa T; Nakano K; Horie T
Am J Physiol Gastrointest Liver Physiol; 2004 Jul; 287(1):G42-9. PubMed ID: 15194559
[TBL] [Abstract][Full Text] [Related]
10. Treatment of hyperbilirubinemia in Eisai hyperbilirubinemic rat by transfecting human MRP2/ABCC2 gene.
Hirouchi M; Suzuki H; Sugiyama Y
Pharm Res; 2005 Apr; 22(4):661-6. PubMed ID: 15846474
[TBL] [Abstract][Full Text] [Related]
11. Drug interaction between sunitinib and cimetidine and contribution of the efflux transporter ATP-binding cassette C2 to biliary excretion of sunitinib in rats.
Arakawa-Todo M; Ueyama J; Nomura H; Abe F; Tsukiyama I; Matsuura K; Hasegawa T
Anticancer Res; 2013 Aug; 33(8):3105-11. PubMed ID: 23898066
[TBL] [Abstract][Full Text] [Related]
12. Increased hepatic and renal expressions of multidrug resistance-associated protein 3 in Eisai hyperbilirubinuria rats.
Kuroda M; Kobayashi Y; Tanaka Y; Itani T; Mifuji R; Araki J; Kaito M; Adachi Y
J Gastroenterol Hepatol; 2004 Feb; 19(2):146-53. PubMed ID: 14731123
[TBL] [Abstract][Full Text] [Related]
13. Role of rat multidrug resistance protein 2 in plasma and biliary disposition of dibromosulfophthalein after microsomal enzyme induction.
Johnson DR; Klaassen CD
Toxicol Appl Pharmacol; 2002 Apr; 180(1):56-63. PubMed ID: 11922777
[TBL] [Abstract][Full Text] [Related]
14. Estimation of transporters involved in the hepatobiliary transport of TA-0201CA using sandwich-cultured rat hepatocytes from normal and multidrug resistance-associated protein 2-deficient rats.
Fukuda H; Ohashi R; Ohashi N; Yabuuchi H; Tamai I
Drug Metab Dispos; 2010 Sep; 38(9):1505-13. PubMed ID: 20538722
[TBL] [Abstract][Full Text] [Related]
15. Biliary excretion of 17beta-estradiol 17beta-D-glucuronide is predominantly mediated by cMOAT/MRP2.
Morikawa A; Goto Y; Suzuki H; Hirohashi T; Sugiyama Y
Pharm Res; 2000 May; 17(5):546-52. PubMed ID: 10888306
[TBL] [Abstract][Full Text] [Related]
16. Biliary excretion of curcumin is mediated by multidrug resistance-associated protein 2.
Lee JH; Oh JH; Lee YJ
Biol Pharm Bull; 2012; 35(5):777-80. PubMed ID: 22687416
[TBL] [Abstract][Full Text] [Related]
17. Mechanism of the tissue distribution and biliary excretion of the cyclic peptide octreotide.
Yamada T; Niinuma K; Lemaire M; Terasaki T; Sugiyama Y
J Pharmacol Exp Ther; 1996 Dec; 279(3):1357-64. PubMed ID: 8968360
[TBL] [Abstract][Full Text] [Related]
18. Enhanced biliary excretion of lithocholate-3-sulfate by ursodeoxycholate-3,7-disulfate infusion in Eisai hyperbilirubinemic rat (EHBR).
Takikawa H; Sano N; Ogasawara T; Yamanaka M
Dig Dis Sci; 1998 Jan; 43(1):188-92. PubMed ID: 9508524
[TBL] [Abstract][Full Text] [Related]
19. Impaired biliary excretion and whole body elimination of methylmercury in rats with congenital defect in biliary glutathione excretion.
Ballatori N; Gatmaitan Z; Truong AT
Hepatology; 1995 Nov; 22(5):1469-73. PubMed ID: 7590665
[TBL] [Abstract][Full Text] [Related]
20. Different biliary excretion systems for glucuronide and sulfate of a model compound; study using Eisai hyperbilirubinemic rats.
Takenaka O; Horie T; Suzuki H; Sugiyama Y
J Pharmacol Exp Ther; 1995 Sep; 274(3):1362-9. PubMed ID: 7562509
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
